Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Funding
Employees
Discover the best career opportunities with the best company cultures for you.
Connect your business to thousands of engaged professionals in your city and beyond.